Page 123 - Read Online
P. 123

Musumeci et al. J Transl Genet Genom 2020;4:221-37  I  https://doi.org/10.20517/jtgg.2020.22                                   Page 227

               Table 4. Parkinsonism associated with mtDNA mutations
               Gene       Mutation       Clinical features of parkinsonism  Other clinical features  Ref.
               MtDNA   Large single deletions  Asymmetrical or symmetrical parkinsonism   PEO  Schreglmann et al. [14] , 2018
               MT-ND4  m.11778G > A  Asymmetrical akinesia, rigidity   LHON             Vital et al. [58] , 2015
                                     Bilateral akinesia, rigidity      LHON             Simon et al. [57] , 1999
               MT-TI   m.4296G > A   Bilateral akinesia, rigidity      LS, hypogonadism  Martikainen et al. [54] , 2013
               MT-TK   m.8344A > G   Asymmetrical akinesia, rigidity, tremor   MERRF    Horvath et al. [53] , 2007
               MT-RNR1  m.1095T > C   Hemiparkinsonism with akinesia, rigidity, tremor   Hypoacusia, neuropathy  Thyagarajan et al. [52] , 2000
               MT-CYB  4 bp deletion   Symmetrical akinesia, rigidity, tremor   Stroke-like episodes  De Coo et al. [55] , 1999

               PEO: progressive external ophthalmoplegia; LHON: Leber hereditary optic neuropathy; MERRF: mitochondrial encephalomyopathy with
               ragged red fibers

               The majority of reports describing a Parkinson-like phenotype in the context of a mitochondrial syndrome
               are associated with mutation in nDNA genes but more rarely extrapyramidal features have been described in
               few cases of mtDNA-related syndromes, such as MERRF, MELAS, and LHON [52-54] . De Coo et al.  reported
                                                                                                [55]
               on a patient with a MELAS-like syndrome with parkinsonism due to a 4-bp deletion in the mitochondrial
               cytochrome B gene (MTCYB) [55,56] . Similarly, bradykinesia and rigidity were reported in LHON cases with
               mutation in ND4 gene [57,58] . The main reports on mtDNA mutations associated with parkinsonism are
               summarized in Table 4.


               Recent studies have demonstrated that the nigrostriatal system is very vulnerable to mitochondrial
                         [59]
               dysfunction , and conditions characterized by an impairment of mtDNA maintenance and consequently
               accumulation of somatic mtDNA damage are frequently associated with a nigrostriatal degeneration with
                                                   [14]
               or without clinical signs of parkinsonism . In the last two decades, several reports have described MD
               cases with a complicated phenotype, including parkinsonian features such as akinesia, resting tremor, and
               rigidity due to mutations in nuclear genes involved in mtDNA maintenance such as POLG, TWNK [60,61] ,
               and, more rarely, OPA1, MPV17, and POLG2 [62-64] . POLG1-related syndromes are the most common forms,
               either dominant or recessive, associated with levodopa responsive parkinsonism with a variable onset of
               the parkinsonism from early to advanced age [65-73] . Nevertheless, parkinsonism has been reported in few
               pathogenic TWNK mutations. TWNK (named also C10orf2) is a gene encoding the Twinkle protein, an
               adenine nucleotide-dependent DNA helicase that is involved in the maintenance of mtDNA integrity.

               Patients showed an asymmetrical parkinsonism with progressive external ophtalmoplegia (PEO) and
               myopathy and a wide range of disease onset from juvenile to adult forms [74-77] .

               In recent years, it has been demonstrated that genes involved in mitochondrial dynamics have impaired
               mtDNA maintenance; among them, mutations in OPA1, but also in AFG3L2 and SPG7, have been related
               to nigrostriatal dysfunction. Some years ago, we described two unrelated families harboring a heterozygous
               dominant OPA1 mutation with a clinical picture characterized by PEO, parkinsonism, cognitive impairment,
               and nigrostriatal dysfunction at DAT-SCAN. Functional studies revealed an imbalance of autophagy and
               mitophagy .
                        [62]

               Recently, among 35 SPG7 patients, parkinsonism was observed in 21% of cases. mtDNA copy number
                                                                                                       [78]
               quantification in blood revealed significantly lower mtDNA levels in either patients or carriers than controls .

               An overview of clinical, genetic, and neuroradiological findings in MD cases with parkinsonism due to
               mitochondrial-related nDNA genes reported in the literature is summarized in Table 5 [79-84] .


               Clinical presentation of mitochondrial parkinsonism (MP) seems not different from idiopathic Parkinson
               disease and for this reason MP can be overlooked. For instance, parkinsonism related to POLG mutations
   118   119   120   121   122   123   124   125   126   127   128